End-of-day quote
Other stock markets
|
||
- EUR | - |
05-29 | 3SBIO Unit to Cooperate on Development, Sale of Weight Management Injection | MT |
04-22 | 3Sbio Inc. Announces Management Changes | CI |
Business Summary
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100.0
%
| 7,977 | 100.0 % | 8,637 | 100.0 % | +8.27% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
97.2
%
| 7,734 | 97.0 % | 8,396 | 97.2 % | +8.56% |
Others
2.8
%
| 243 | 3.0 % | 240 | 2.8 % | -1.03% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jing Lou
CEO | Chief Executive Officer | 61 | 31/12/92 |
Xiang He
DFI | Director of Finance/CFO | - | 02/07/23 |
Dong Mei Su
BRD | Director/Board Member | 54 | 10/06/12 |
Bin Huang
BRD | Director/Board Member | 63 | 31/12/92 |
Dong Tao Luo
PRN | Corporate Officer/Principal | 48 | 29/02/16 |
Xin Ma
HRO | Human Resources Officer | 58 | - |
Siu Kuen Lai
SEC | Corporate Secretary | 48 | 26/11/14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bin Huang
BRD | Director/Board Member | 63 | 31/12/92 |
Jing Lou
CEO | Chief Executive Officer | 61 | 31/12/92 |
Dong Mei Su
BRD | Director/Board Member | 54 | 10/06/12 |
Tian Ruo Pu
BRD | Director/Board Member | 55 | 31/05/15 |
Joo Yeow Ng
BRD | Director/Board Member | 59 | 20/01/22 |
Hoi Ti Yang
BRD | Director/Board Member | 54 | 28/06/21 |
Dan Zhang
BRD | Director/Board Member | 60 | 29/12/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,438,920,412 | 1,802,803,951 ( 73.92 %) | 40,357,688 ( 1.655 %) | 73.92 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
498,883,645 | 95.20% | 1,650,661,305 $ | |
SENSORION 1.35% | 4,055,150 | 1.35% | 3,026,521 $ |
Company contact information
3SBio, Inc.
Shenyang Economy & Tech Development No. 3 A1, Road 10
110027, Shenyang
+86 24 2538 6000
http://www.3sbio.comGroup companies
Name | Category and Sector |
---|---|
Hongkong Sansheng Medical Ltd.
Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong. |
Pharmaceuticals: Major
|
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-2.29% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B |
- Stock Market
- Equities
- 1530 Stock
- YFK Stock
- Company 3SBio Inc. (ADR)